There’s no nice way to hear the word fat about any body part, even one you didn’t know could be judged! Fatty liver disease is one of the most common conditions in people with type 2 diabetes, but it often flies under the radar until advanced stages. Dr. E explains who should be screened (and when), how it’s diagnosed, and the two newly approved medications that can help slow its progression.
[read_more text="read more" title="read more" url="https://tcoyd.org/2026/02/masld-ask-dr-e/" align="left"]Liver disease affects up to 70% of people with type 2 diabetes, and often there are no noticeable symptoms. For those who have risk factors such as obesity, hypertension, insulin resistance and/or high cholesterol, early detection is crucial to allow for timely treatment and a reduced chance of developing other serious complications.
[read_more text="read more" title="read more" url="https://tcoyd.org/2024/01/what-to-know-about-masld-and-mash-two-liver-conditions-that-can-affect-people-with-diabetes/" align="left"]

